These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26554885)

  • 21. How I manage children with neutropenia.
    Dale DC
    Br J Haematol; 2017 Aug; 178(3):351-363. PubMed ID: 28419427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How we diagnose and treat neutropenia in adults.
    Palmblad J; Nilsson CC; Höglund P; Papadaki HA
    Expert Rev Hematol; 2016 May; 9(5):479-87. PubMed ID: 26778239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
    Hartmann LC; Tschetter LK; Habermann TM; Ebbert LP; Johnson PS; Mailliard JA; Levitt R; Suman VJ; Witzig TE; Wieand HS; Miller LL; Moertel CG
    N Engl J Med; 1997 Jun; 336(25):1776-80. PubMed ID: 9187067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.
    Mitchell PL; Morland B; Stevens MC; Dick G; Easlea D; Meyer LC; Pinkerton CR
    J Clin Oncol; 1997 Mar; 15(3):1163-70. PubMed ID: 9060560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases.
    Rose C; Wattel E; Bastion Y; Berger E; Bauters F; Coiffier B; Fenaux P
    Leukemia; 1994 Sep; 8(9):1458-62. PubMed ID: 8090025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders].
    Takeyama H; Yamada H; Emi N; Saito H; Takeshita A; Ohno R; Yoshida H; Naoe T; Kageyama S; Shirakawa S
    Rinsho Ketsueki; 1995 Nov; 36(11):1257-65. PubMed ID: 8691565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced Neutropenia.
    Yalçin Ş; Güler N; Kansu E; Ertenli I; Güllü I; Barişta I; Çelik I; Kars A; Tekuzman G; Baltali E; Firat D
    Hematology; 1996; 1(2):155-61. PubMed ID: 27406430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.
    Ohno R; Miyawaki S; Hatake K; Kuriyama K; Saito K; Kanamaru A; Kobayashi T; Kodera Y; Nishikawa K; Matsuda S; Yamada O; Omoto E; Takeyama H; Tsukuda K; Asou N; Tanimoto M; Shiozaki H; Tomonaga M; Masaoka T; Miura Y; Takaku F; Ohashi Y; Motoyoshi K
    J Clin Oncol; 1997 Aug; 15(8):2954-65. PubMed ID: 9256140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
    Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
    Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
    Ho P; Sherman P; Grigg A
    Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Shi YK; Sun Y; Su M
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
    Milano-Bausset E; Gaudart J; Rome A; Coze C; Gentet JC; Padovani L; Lacarelle B; André N
    Clin Ther; 2009; 31 Pt 2():2388-95. PubMed ID: 20110048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevention of febrile neutropenia.
    Pascoe J; Cullen M
    Curr Opin Oncol; 2006 Jul; 18(4):325-9. PubMed ID: 16721125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital neutropenias.
    Zeidler C; Schwinzer B; Welte K
    Rev Clin Exp Hematol; 2003 Mar; 7(1):72-83. PubMed ID: 14692235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of neutrophil number and function.
    Newburger PE
    Hematology Am Soc Hematol Educ Program; 2006; ():104-10. PubMed ID: 17124047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.